EDGAR Filing Documents for 0001047469-03-011133

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-03-011133

Filing Date

2003-03-31

Accepted

2003-03-31 12:14:03

Documents

Period of Report

2002-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	a2106829z10-k.htm	10-K	607982
3	EXHIBIT 4.7	a2106829zex-4_7.htm	EX-4.7	78386
4	EXHIBIT 4.10	a2106829zex-4_10.htm	EX-4.10	82190
5	EXHIBIT 4.11	a2106829zex-4_11.htm	EX-4.11	73647
6	EXHIBIT 10.2	a2106829zex-10_2.htm	EX-10.2	102767
7	EXHIBIT 10.20	a2106829zex-10_20.htm	EX-10.20	84581
8	EXHIBIT 10.26	a2106829zex-10_26.htm	EX-10.26	34489
9	EXHIBIT 10.27	a2106829zex-10_27.htm	EX-10.27	396417
10	EXHIBIT 23.1	a2106829zex-23_1.htm	EX-23.1	2243
11	EXHIBIT 99.1	a2106829zex-99_1.htm	EX-99.1	7434
12	G258953.JPG	g258953.jpg	GRAPHIC	49139
	Complete submission text file	0001047469-03-011133.txt		1521942

Mailing Address 240 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 240 E GRAND AVE SOUTH SAN FRANCISCO CA 94080

RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)